The 2nd Cell Therapy for Autoimmune Disease Summit returns to Philadelphia bigger and better after last year’s explosive debut as the only meeting covering every aspect of bringing cell therapies to the autoimmune space.

This year’s agenda brings you the opportunity to learn the A-Zs of accelerating your candidates to be the first in the market and finally bring the cure for an autoimmune indication. Leading experts including Cartesian Therapeutics, Bristol Myers Squibb, the University of Pennsylvania, ImmPACT Bio and more, will cover their latest clinical updates, next-generation candidates, novel antigen targets, and translational biomarkers to turbocharge the development of cell therapies for autoimmune disease.

This is your chance to connect with top cell therapy pioneers, clinicians, investors, and wavemakers who share a focus on accelerating this approach for autoimmune patients to realize a curative treatment.

Find out more here.